[Villoglandular adenocarcinoma of cervix:a clinicopathological study].
Liu
Zheng-cao
ZC
liuzc@sj-hospital.org
Zheng
Lu
L
Huo
Yun-long
YL
Yang
Xiang-hong
XH
Gao
Ai-feng
AF
Cui
Xiu-juan
XJ
D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D018262:Adenocarcinoma, Clear Cell / Q000378:metabolism / Q000473:pathology; D000328:Adult; D018394:CA-125 Antigen / Q000378:metabolism; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D018284:Cystadenocarcinoma, Serous / Q000378:metabolism / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D019394:Ki-67 Antigen / Q000378:metabolism; D008197:Lymph Node Excision; D008565:Membrane Proteins / Q000378:metabolism; D009361:Neoplasm Invasiveness; D002583:Uterine Cervical Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D002578:Uterine Cervical Dysplasia / Q000378:metabolism / Q000473:pathology* / Q000601:surgery
D018394:CA-125 Antigen; D002272:Carcinoembryonic Antigen; D019394:Ki-67 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins